Drug dosing for renoprotection: maybe it's time for a drug efficacy-safety score?

J Am Soc Nephrol. 2009 Apr;20(4):688-9. doi: 10.1681/ASN.2009020172. Epub 2009 Mar 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Angiotensin II Type 1 Receptor Blockers / therapeutic use*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Biphenyl Compounds
  • Captopril / therapeutic use
  • Dose-Response Relationship, Drug
  • Humans
  • Hypertension / drug therapy
  • Kidney Diseases / drug therapy
  • Kidney Diseases / prevention & control*
  • Proteinuria / drug therapy*
  • Tetrazoles / therapeutic use*

Substances

  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • Captopril
  • candesartan